10-K Filing

HEALTHTECH SOLUTIONS, INC./UT CIK: 1307624 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001262463-20-000353`
Period End Date	20200630
Filing Date	20200904
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	hybg-20200630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 29 Income Statement 18 Cash Flow Statement 22 Stockholders Equity 12

Balance Sheet 29 line items

Line Item	Tag	Value	Unit	Period
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.70M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.70M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.70M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.70M	shares	Point-in-time
Total Current Assets and Total Assets	`Assets`	-	USD	Point-in-time
Total Current Assets and Total Assets	`Assets`	-	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrent`	$4.82K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrent`	$25.71K	USD	Point-in-time
Loan payable - related party	`DueToRelatedPartiesCurrent`	$13.30K	USD	Point-in-time
Loan payable - related party	`DueToRelatedPartiesCurrent`	$1.20K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.00K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$5.50K	USD	Point-in-time
Total Current Liabilities and Total Liabilities	`LiabilitiesCurrent`	$7.02K	USD	Point-in-time
Total Current Liabilities and Total Liabilities	`LiabilitiesCurrent`	$44.51K	USD	Point-in-time
Common Stock, $0.001 par value, 200,000,000 shares authorized, 9,701,269 issued and outstanding	`CommonStockValue`	$9.70K	USD	Point-in-time
Common Stock, $0.001 par value, 200,000,000 shares authorized, 9,701,269 issued and outstanding	`CommonStockValue`	$9.70K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-54.21K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-16.72K	USD	Point-in-time
Total Stockholders' Deficit	`StockholdersEquity`	$-7.02K	USD	Point-in-time
Total Stockholders' Deficit	`StockholdersEquity`	$-44.51K	USD	Point-in-time
Total Stockholders' Deficit	`StockholdersEquity`	$-1.65K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	-	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	-	USD	Point-in-time

Income Statement 18 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	-	USD	Annual
Revenues	`Revenues`	-	USD	Annual
General & administrative	`GeneralAndAdministrativeExpense`	$1.30K	USD	Annual
General & administrative	`GeneralAndAdministrativeExpense`	$16.60K	USD	Annual
General & administrative - related party	`RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty`	$4.06K	USD	Annual
General & administrative - related party	`RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty`	$20.89K	USD	Annual
Total Operating Expenses	`OperatingExpenses`	$37.49K	USD	Annual
Total Operating Expenses	`OperatingExpenses`	$5.37K	USD	Annual
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-37.49K	USD	Annual
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-5.37K	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net Loss	`NetIncomeLoss`	$-5.37K	USD	Annual
Net Loss	`NetIncomeLoss`	$-37.49K	USD	Annual
(Loss) per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	Annual
(Loss) per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	Annual
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.70M	shares	Annual
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.70M	shares	Annual

Cash Flow Statement 22 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-5.37K	USD	Annual
Net loss	`NetIncomeLoss`	$-37.49K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$4.50K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-590.00	USD	Annual
Loan payable - related party	`IncreaseDecreaseInDueToRelatedParties`	$1.20K	USD	Annual
Loan payable - related party	`IncreaseDecreaseInDueToRelatedParties`	$12.10K	USD	Annual
Accounts payable - related party	`IncreaseDecreaseInAccountsPayableRelatedParties`	$20.89K	USD	Annual
Accounts payable - related party	`IncreaseDecreaseInAccountsPayableRelatedParties`	$4.75K	USD	Annual
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	-	USD	Annual
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	-	USD	Annual
Net change in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	-	USD	Annual
Net change in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	-	USD	Annual
Cash, cash equivalents, and restricted cash beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash, cash equivalents, and restricted cash beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash, cash equivalents, and restricted cash beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash, cash equivalents, and restricted cash end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash, cash equivalents, and restricted cash end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash, cash equivalents, and restricted cash end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Cash paid for interest	`InterestPaidNet`	-	USD	Annual
Cash paid for interest	`InterestPaidNet`	-	USD	Annual

Stockholders Equity 12 line items

Line Item	Tag	Value	Unit	Period
Balance common stock, shares	`CommonStockSharesOutstanding`	9.70M	shares	Point-in-time
Balance common stock, shares	`CommonStockSharesOutstanding`	9.70M	shares	Point-in-time
Balance, value	`StockholdersEquity`	$-7.02K	USD	Point-in-time
Balance, value	`StockholdersEquity`	$-44.51K	USD	Point-in-time
Balance, value	`StockholdersEquity`	$-1.65K	USD	Point-in-time
Net Loss	`NetIncomeLoss`	$-5.37K	USD	Annual
Net Loss	`NetIncomeLoss`	$-37.49K	USD	Annual
Balance common stock, shares	`CommonStockSharesOutstanding`	9.70M	shares	Point-in-time
Balance common stock, shares	`CommonStockSharesOutstanding`	9.70M	shares	Point-in-time
Balance, value	`StockholdersEquity`	$-7.02K	USD	Point-in-time
Balance, value	`StockholdersEquity`	$-44.51K	USD	Point-in-time
Balance, value	`StockholdersEquity`	$-1.65K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.